Evaluating the safety and efficacy of the leukotriene receptor antagonist montelukast as adjuvant therapy in obese patients with type 2 diabetes mellitus: A double-blind, randomized, placebo-controlled trial

• Principais autores: Eman El-Khateeb (Autor), Eman I. El-Berri (Autor), Esraa M. Mosalam (Autor), Mohamed Z. Nooh (Autor), Shimaa Abdelsattar (Autor), Amira M. Alghamdi (Autor), Sarah Alrubia (Autor), Mahmoud S. Abdallah (Autor)
• Formato: Livro
• Publicado em: Frontiers Media S.A., 2023-04-01T00:00:00Z.
• Assuntos: article
• Acesso em linha: Connect to this object online.

Background: Type 2 diabetes mellitus (T2DM) is common with obesity. Metformin is a first-line therapy for this condition. However, it has only a minor impact on weight loss in some patients.Aim: This study aimed to evaluate the effectiveness, tolerability, and safety of combining montelukast therapy...